Annual D&A
$97.22 M
+$3.91 M+4.19%
31 March 2024
Summary:
Haemonetics annual depreciation & amortization is currently $97.22 million, with the most recent change of +$3.91 million (+4.19%) on 31 March 2024. During the last 3 years, it has risen by +$12.93 million (+15.34%). HAE annual D&A is now -11.85% below its all-time high of $110.29 million, reached on 28 March 2020.HAE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$29.22 M
+$81.00 K+0.28%
28 September 2024
Summary:
Haemonetics quarterly depreciation & amortization is currently $29.22 million, with the most recent change of +$81.00 thousand (+0.28%) on 28 September 2024. Over the past year, it has increased by +$6.20 million (+26.96%). HAE quarterly D&A is now -1.89% below its all-time high of $29.78 million, reached on 30 March 2019.HAE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$109.52 M
+$6.20 M+6.00%
28 September 2024
Summary:
Haemonetics TTM depreciation & amortization is currently $109.52 million, with the most recent change of +$6.20 million (+6.00%) on 28 September 2024. Over the past year, it has increased by +$16.05 million (+17.18%). HAE TTM D&A is now -2.38% below its all-time high of $112.19 million, reached on 28 September 2019.HAE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.2% | +27.0% | +17.2% |
| 3 y3 years | +15.3% | +19.9% | +15.5% |
| 5 y5 years | -11.2% | +8.1% | -2.4% |
HAE Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.5% | +15.3% | at high | +30.2% | at high | +20.0% |
| 5 y | 5 years | -11.8% | +15.3% | at high | +41.0% | -2.4% | +29.9% |
| alltime | all time | -11.8% | +1288.8% | -1.9% | +5743.4% | -2.4% | +5984.6% |
Haemonetics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $29.22 M(+0.3%) | $109.52 M(+6.0%) |
| June 2024 | - | $29.14 M(+5.4%) | $103.32 M(+6.3%) |
| Mar 2024 | $97.22 M(+4.2%) | - | - |
| Mar 2024 | - | $27.64 M(+17.5%) | $97.22 M(+4.1%) |
| Dec 2023 | - | $23.53 M(+2.3%) | $93.43 M(-0.0%) |
| Sept 2023 | - | $23.01 M(-0.1%) | $93.47 M(-0.5%) |
| June 2023 | - | $23.03 M(-3.4%) | $93.89 M(+0.6%) |
| Mar 2023 | $93.31 M(-4.5%) | $23.85 M(+1.2%) | $93.31 M(-1.0%) |
| Dec 2022 | - | $23.57 M(+0.6%) | $94.27 M(-0.8%) |
| Sept 2022 | - | $23.44 M(+4.4%) | $95.06 M(-0.1%) |
| June 2022 | - | $22.45 M(-9.5%) | $95.16 M(-2.6%) |
| Mar 2022 | $97.75 M(+16.0%) | $24.81 M(+1.8%) | $97.75 M(+3.1%) |
| Dec 2021 | - | $24.37 M(+3.5%) | $94.84 M(+3.9%) |
| Sept 2021 | - | $23.53 M(-6.0%) | $91.25 M(+3.0%) |
| June 2021 | - | $25.03 M(+14.3%) | $88.60 M(+5.1%) |
| Mar 2021 | $84.29 M(-23.6%) | $21.91 M(+5.5%) | $84.29 M(-7.5%) |
| Dec 2020 | - | $20.77 M(-0.5%) | $91.14 M(-6.4%) |
| Sept 2020 | - | $20.88 M(+0.7%) | $97.42 M(-5.9%) |
| June 2020 | - | $20.72 M(-28.0%) | $103.58 M(-6.1%) |
| Mar 2020 | $110.29 M(+0.8%) | $28.77 M(+6.3%) | $110.29 M(-0.9%) |
| Dec 2019 | - | $27.05 M(+0.1%) | $111.31 M(-0.8%) |
| Sept 2019 | - | $27.03 M(-1.5%) | $112.19 M(+1.6%) |
| June 2019 | - | $27.44 M(-7.9%) | $110.44 M(+0.9%) |
| Mar 2019 | $109.42 M(+22.6%) | $29.78 M(+6.6%) | $109.42 M(+6.6%) |
| Dec 2018 | - | $27.95 M(+10.6%) | $102.62 M(+5.8%) |
| Sept 2018 | - | $25.28 M(-4.3%) | $96.95 M(+3.3%) |
| June 2018 | - | $26.41 M(+14.9%) | $93.87 M(+5.2%) |
| Mar 2018 | $89.25 M(-0.5%) | $22.98 M(+3.1%) | $89.25 M(+0.9%) |
| Dec 2017 | - | $22.28 M(+0.4%) | $88.47 M(+0.0%) |
| Sept 2017 | - | $22.20 M(+1.9%) | $88.47 M(-0.6%) |
| June 2017 | - | $21.79 M(-1.9%) | $88.98 M(-0.8%) |
| Mar 2017 | $89.73 M(-0.2%) | $22.20 M(-0.3%) | $89.73 M(+0.0%) |
| Dec 2016 | - | $22.28 M(-1.9%) | $89.72 M(-0.5%) |
| Sept 2016 | - | $22.71 M(+0.7%) | $90.17 M(-0.0%) |
| June 2016 | - | $22.54 M(+1.6%) | $90.20 M(+0.3%) |
| Mar 2016 | $89.91 M(+4.5%) | $22.19 M(-2.3%) | $89.91 M(+0.0%) |
| Dec 2015 | - | $22.72 M(-0.1%) | $89.88 M(+0.5%) |
| Sept 2015 | - | $22.74 M(+2.2%) | $89.43 M(+1.9%) |
| June 2015 | - | $22.25 M(+0.4%) | $87.80 M(+2.0%) |
| Mar 2015 | $86.05 M(+5.3%) | $22.16 M(-0.5%) | $86.05 M(-0.6%) |
| Dec 2014 | - | $22.27 M(+5.5%) | $86.57 M(+1.7%) |
| Sept 2014 | - | $21.11 M(+2.9%) | $85.11 M(+1.4%) |
| June 2014 | - | $20.51 M(-9.6%) | $83.89 M(+2.6%) |
| Mar 2014 | $81.74 M(+24.8%) | $22.68 M(+9.0%) | $81.74 M(+5.1%) |
| Dec 2013 | - | $20.81 M(+4.6%) | $77.80 M(+3.6%) |
| Sept 2013 | - | $19.90 M(+8.4%) | $75.13 M(+3.4%) |
| June 2013 | - | $18.36 M(-2.0%) | $72.66 M(+11.0%) |
| Mar 2013 | $65.48 M(+31.1%) | $18.74 M(+3.4%) | $65.48 M(+10.1%) |
| Dec 2012 | - | $18.13 M(+4.0%) | $59.45 M(+10.2%) |
| Sept 2012 | - | $17.43 M(+55.9%) | $53.96 M(+9.8%) |
| June 2012 | - | $11.18 M(-12.0%) | $49.16 M(-1.6%) |
| Mar 2012 | $49.97 M(+3.8%) | $12.71 M(+0.6%) | $49.97 M(+3.3%) |
| Dec 2011 | - | $12.64 M(+0.0%) | $48.38 M(+0.6%) |
| Sept 2011 | - | $12.63 M(+5.4%) | $48.07 M(+0.7%) |
| June 2011 | - | $11.99 M(+7.8%) | $47.72 M(-0.9%) |
| Mar 2011 | $48.15 M(+11.4%) | $11.12 M(-9.9%) | $48.15 M(-0.7%) |
| Dec 2010 | - | $12.34 M(+0.4%) | $48.48 M(+2.7%) |
| Sept 2010 | - | $12.28 M(-1.0%) | $47.23 M(+3.6%) |
| June 2010 | - | $12.41 M(+8.3%) | $45.59 M(+5.4%) |
| Mar 2010 | $43.24 M(+18.6%) | $11.46 M(+3.4%) | $43.24 M(+12.6%) |
| Dec 2009 | - | $11.08 M(+4.1%) | $38.40 M(-1.7%) |
| Sept 2009 | - | $10.64 M(+5.8%) | $39.08 M(+1.4%) |
| June 2009 | - | $10.06 M(+51.9%) | $38.53 M(+5.7%) |
| Mar 2009 | $36.46 M(+16.9%) | $6.62 M(-43.7%) | $36.46 M(-5.6%) |
| Dec 2008 | - | $11.76 M(+16.5%) | $38.64 M(+11.7%) |
| Sept 2008 | - | $10.10 M(+26.4%) | $34.59 M(+8.1%) |
| June 2008 | - | $7.99 M(-9.2%) | $32.00 M(+2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | $31.20 M(+13.4%) | $8.80 M(+14.1%) | $31.20 M(+8.0%) |
| Dec 2007 | - | $7.71 M(+2.8%) | $28.88 M(+2.9%) |
| Sept 2007 | - | $7.50 M(+4.5%) | $28.07 M(+0.5%) |
| June 2007 | - | $7.18 M(+10.8%) | $27.94 M(+1.6%) |
| Mar 2007 | $27.50 M(+9.4%) | $6.48 M(-6.2%) | $27.50 M(-0.7%) |
| Dec 2006 | - | $6.91 M(-6.4%) | $27.69 M(+2.6%) |
| Sept 2006 | - | $7.38 M(+9.4%) | $26.98 M(+1.6%) |
| June 2006 | - | $6.74 M(+1.2%) | $26.56 M(+5.6%) |
| Mar 2006 | $25.15 M(-8.8%) | $6.67 M(+7.5%) | $25.15 M(-0.7%) |
| Dec 2005 | - | $6.20 M(-10.8%) | $25.34 M(-0.8%) |
| Sept 2005 | - | $6.95 M(+30.4%) | $25.53 M(-0.8%) |
| June 2005 | - | $5.33 M(-22.2%) | $25.75 M(-6.6%) |
| Mar 2005 | $27.58 M(-8.5%) | $6.85 M(+7.2%) | $27.58 M(-0.4%) |
| Dec 2004 | - | $6.39 M(-10.8%) | $27.68 M(-4.1%) |
| Sept 2004 | - | $7.17 M(+0.1%) | $28.87 M(-2.9%) |
| June 2004 | - | $7.16 M(+2.9%) | $29.73 M(-1.4%) |
| Mar 2004 | $30.15 M(+6.0%) | $6.96 M(-8.3%) | $30.15 M(+2.4%) |
| Dec 2003 | - | $7.59 M(-5.4%) | $29.45 M(-1.1%) |
| Sept 2003 | - | $8.02 M(+5.7%) | $29.78 M(+2.9%) |
| June 2003 | - | $7.58 M(+21.1%) | $28.95 M(+1.8%) |
| Mar 2003 | $28.43 M(+11.0%) | $6.26 M(-20.9%) | $28.43 M(-0.4%) |
| Dec 2002 | - | $7.92 M(+10.1%) | $28.56 M(+17.1%) |
| Sept 2002 | - | $7.19 M(+1.8%) | $24.38 M(-9.2%) |
| June 2002 | - | $7.06 M(+10.5%) | $26.84 M(+4.8%) |
| Mar 2002 | $25.62 M(+4.6%) | $6.39 M(+70.9%) | $25.62 M(-0.4%) |
| Dec 2001 | - | $3.74 M(-61.3%) | $25.72 M(-8.2%) |
| Sept 2001 | - | $9.65 M(+65.3%) | $28.01 M(+15.2%) |
| June 2001 | - | $5.84 M(-10.1%) | $24.31 M(-0.8%) |
| Mar 2001 | $24.50 M(-1.6%) | $6.49 M(+7.6%) | $24.50 M(+15.0%) |
| Dec 2000 | - | $6.03 M(+1.5%) | $21.31 M(+3.1%) |
| Sept 2000 | - | $5.95 M(-1.4%) | $20.68 M(-12.1%) |
| June 2000 | - | $6.03 M(+82.3%) | $23.53 M(-5.5%) |
| Mar 2000 | $24.91 M(+1.4%) | $3.31 M(-38.8%) | $24.91 M(-2.6%) |
| Dec 1999 | - | $5.40 M(-38.6%) | $25.57 M(-3.4%) |
| Sept 1999 | - | $8.80 M(+18.9%) | $26.47 M(-1.5%) |
| June 1999 | - | $7.40 M(+86.3%) | $26.87 M(+9.4%) |
| Mar 1999 | $24.57 M(+7.3%) | $3.97 M(-36.9%) | $24.57 M(-10.3%) |
| Dec 1998 | - | $6.30 M(-31.5%) | $27.40 M(+7.9%) |
| Sept 1998 | - | $9.20 M(+80.4%) | $25.40 M(+11.9%) |
| June 1998 | - | $5.10 M(-25.0%) | $22.70 M(-0.9%) |
| Mar 1998 | $22.90 M(+17.4%) | $6.80 M(+58.1%) | $22.90 M(-9.5%) |
| Dec 1997 | - | $4.30 M(-33.8%) | $25.30 M(+0.8%) |
| Sept 1997 | - | $6.50 M(+22.6%) | $25.10 M(+16.2%) |
| June 1997 | - | $5.30 M(-42.4%) | $21.60 M(+10.8%) |
| Mar 1997 | $19.50 M(+48.9%) | $9.20 M(+124.4%) | $19.50 M(+80.6%) |
| Dec 1996 | - | $4.10 M(+36.7%) | $10.80 M(-0.9%) |
| Sept 1996 | - | $3.00 M(-6.3%) | $10.90 M(-9.9%) |
| June 1996 | - | $3.20 M(+540.0%) | $12.10 M(-7.6%) |
| Mar 1996 | $13.10 M(-4.4%) | $500.00 K(-88.1%) | $13.10 M(-15.5%) |
| Dec 1995 | - | $4.20 M(0.0%) | $15.50 M(+3.3%) |
| Sept 1995 | - | $4.20 M(0.0%) | $15.00 M(+4.9%) |
| June 1995 | - | $4.20 M(+44.8%) | $14.30 M(+4.4%) |
| Mar 1995 | $13.70 M(+28.0%) | $2.90 M(-21.6%) | $13.70 M(+5.4%) |
| Dec 1994 | - | $3.70 M(+5.7%) | $13.00 M(+8.3%) |
| Sept 1994 | - | $3.50 M(-2.8%) | $12.00 M(+3.4%) |
| June 1994 | - | $3.60 M(+63.6%) | $11.60 M(+8.4%) |
| Mar 1994 | $10.70 M(+25.9%) | $2.20 M(-18.5%) | $10.70 M(+4.9%) |
| Dec 1993 | - | $2.70 M(-12.9%) | $10.20 M(+3.0%) |
| Sept 1993 | - | $3.10 M(+14.8%) | $9.90 M(+10.0%) |
| June 1993 | - | $2.70 M(+58.8%) | $9.00 M(+5.9%) |
| Mar 1993 | $8.50 M(+21.4%) | $1.70 M(-29.2%) | $8.50 M(+3.7%) |
| Dec 1992 | - | $2.40 M(+9.1%) | $8.20 M(+6.5%) |
| Sept 1992 | - | $2.20 M(0.0%) | $7.70 M(+4.1%) |
| June 1992 | - | $2.20 M(+57.1%) | $7.40 M(+5.7%) |
| Mar 1992 | $7.00 M | $1.40 M(-26.3%) | $7.00 M(+25.0%) |
| Dec 1991 | - | $1.90 M(0.0%) | $5.60 M(+51.4%) |
| Sept 1991 | - | $1.90 M(+5.6%) | $3.70 M(+105.6%) |
| June 1991 | - | $1.80 M | $1.80 M |
FAQ
- What is Haemonetics annual depreciation & amortization?
- What is the all time high annual D&A for Haemonetics?
- What is Haemonetics annual D&A year-on-year change?
- What is Haemonetics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Haemonetics?
- What is Haemonetics quarterly D&A year-on-year change?
- What is Haemonetics TTM depreciation & amortization?
- What is the all time high TTM D&A for Haemonetics?
- What is Haemonetics TTM D&A year-on-year change?
What is Haemonetics annual depreciation & amortization?
The current annual D&A of HAE is $97.22 M
What is the all time high annual D&A for Haemonetics?
Haemonetics all-time high annual depreciation & amortization is $110.29 M
What is Haemonetics annual D&A year-on-year change?
Over the past year, HAE annual depreciation & amortization has changed by +$3.91 M (+4.19%)
What is Haemonetics quarterly depreciation & amortization?
The current quarterly D&A of HAE is $29.22 M
What is the all time high quarterly D&A for Haemonetics?
Haemonetics all-time high quarterly depreciation & amortization is $29.78 M
What is Haemonetics quarterly D&A year-on-year change?
Over the past year, HAE quarterly depreciation & amortization has changed by +$6.20 M (+26.96%)
What is Haemonetics TTM depreciation & amortization?
The current TTM D&A of HAE is $109.52 M
What is the all time high TTM D&A for Haemonetics?
Haemonetics all-time high TTM depreciation & amortization is $112.19 M
What is Haemonetics TTM D&A year-on-year change?
Over the past year, HAE TTM depreciation & amortization has changed by +$16.05 M (+17.18%)